Review
Raynaud's phenomenon (primary)
Affiliations
- PMID: 12967424
Item in Clipboard
Review
Raynaud's phenomenon (primary)
Clin Evid.
2003 Jun.
Update in
-
Raynaud's (primary).Clin Evid. 2003 Dec;(10):1444-53. Clin Evid. 2003. Update in: Clin Evid. 2004 Dec;(12):1725-34. PMID: 15555156 Updated. Review. No abstract available.
No abstract available
Similar articles
-
Raynaud's phenomenon (primary).Clin Evid. 2005 Jun;(13):1546-54. Clin Evid. 2005. PMID: 16135302 Review. No abstract available.
-
Raynaud's phenomenon (primary).Clin Evid. 2004 Dec;(12):1725-34. Clin Evid. 2004. Update in: Clin Evid. 2005 Jun;(13):1546-54. PMID: 15865744 Updated. Review. No abstract available.
-
Raynaud's (primary).Clin Evid. 2003 Dec;(10):1444-53. Clin Evid. 2003. Update in: Clin Evid. 2004 Dec;(12):1725-34. PMID: 15555156 Updated. Review. No abstract available.
-
Rational use of calcium-channel antagonists in Raynaud's phenomenon.Curr Opin Rheumatol. 1998 Nov;10(6):584-8. doi: 10.1097/00002281-199811000-00013. Curr Opin Rheumatol. 1998. PMID: 9812220
-
Syncope and Raynaud's disease.Arch Neurol. 2012 May;69(5):608-13. doi: 10.1001/archneurol.2011.1168. Arch Neurol. 2012. PMID: 22248476
Cited by
-
The diagnosis and treatment of Raynaud's phenomenon: a practical approach.Drugs. 2007;67(4):517-25. doi: 10.2165/00003495-200767040-00003. Drugs. 2007. PMID: 17352512 Review.
-
The efficacy and safety of Sipjeondaebo-tang in Korean patients with cold hypersensitivity in the hands and feet: a protocol for a pilot, randomized, double-blind, placebo-controlled, parallel-group clinical trial.Trials. 2019 Apr 15;20(1):217. doi: 10.1186/s13063-019-3286-7. Trials. 2019. PMID: 30987667 Free PMC article.